Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
Free Cash Flow
Compugen Ltd
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Compugen Ltd
NASDAQ:CGEN
|
Free Cash Flow
$-32.7m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-17%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Free Cash Flow
$-7.9m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Free Cash Flow
₪-11m
|
CAGR 3-Years
7%
|
CAGR 5-Years
13%
|
CAGR 10-Years
8%
|
See Also
What is Compugen Ltd's Free Cash Flow?
Free Cash Flow
-32.7m
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Free Cash Flow amounts to -32.7m USD.
What is Compugen Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-17%
Over the last year, the Free Cash Flow growth was 6%. The average annual Free Cash Flow growth rates for Compugen Ltd have been -5% over the past three years , -19% over the past five years , and -17% over the past ten years .